Pharmacy
- Drug Formulary
Molina Healthcare of Nebraska (Molina) is in alignment with Nebraska Medicaid’s Preferred Drug List (PDL). The list shows all the prescription and over-the-counter products members can get from a pharmacy. Some medications require prior authorization (PA) or have limitations on age, dosage and/or quantities. Molina complies with all of Nebraska Medicaid’s criteria found within the comprehensive PDL.
Nebraska Medicaid Preferred Drug List
Formulary Searchable Tool
Medical Preferred Drug List_January 2025 - Prior Authorizations
Molina’s decisions are based upon the information included with the PA request. Clinical notes are recommended.
- Clinical Criteria
Pharmacy Policy Update Memos
Nebraska Medicaid Clinical Criteria
Growth Hormone (GH)
Hepatitis C – Effective 01/01/2024
Insulin-like Growth Factor (IFG) for Children
Molina Medicaid Clinical Criteria
Abilify MyCite Kit (aripiprazole tablets with sensor) MNR
Adakveo (crizanlizumab-tmca) C17920-A1Aldurazyme (laronidase) C28302-A1
Amvuttra (vutrisiran) C24213-A
Antimalarial Agents
Atypical Antipsychotics
Cablivi (caplacizumab-yhdp) C19481-A
Calcitonin Gene-Related Peptide (CGRP) Antagonist C15443-C
Camzyos (mavacamten)
Chemet (succimer)
Crysvita (burosumab-twza) C14517-A
Cuvposa (glycopyrrolate) oral solution
Daraprim (pyrimethamine)
Desmopressin Nasal and Oral (DDAVP)
Diabetic Testing Supplies
Duplication of Therapy/High Risk Combination
Egrifta SV (tesamorelin) MNR
Elaprase (idursulfase) C2720-A
Empaveli (pegcetacoplan)
Entyvio (vedolizumab) C6773-A
Enzyme Replacement Therapy C9674-A
Epidiolex (cannabidiol)
Erythropoiesis-stimulating agents (ESAs) C15389-A
Evenity (romosozumab-aqqg) C17324-A
Evrysdi (risdiplam)
Exondys 51 (eteplirsen) MNR C18464-A
Fabrazyme (agalsidase beta) C4865-A
Filspari (sparsentan)
Filsuvez birch triterpenes gel C27686-A
Firdapse (amifampridine)
Furoscix (furosemide injection)
Galafold (migalastat)
Gattex (teduglutide [rDNA origin])
Gender Dysphoria Hormone Therapy
Givlaari (givosiran) C17924-A
Hemostatic Agents
High-Cost Outlier Targeted Drug Exception
iDose TR travoprost intracameral implant C27707-A
Igalmi (dexmedetomidine)
Imcivree (setmelanotide) NC C22214-A
Immunoglobulin (SCIg, IVIg) C21554-A
Infliximab and Biosimilars C10421-A
InPen (Insulin Smart Pen) NC C21865-A
Insulin Patch NC C24238-A
Iron Chelating Agents (Desferal, Exjade, Ferriprox, Jadenu)
Iron Deficiency Anemia Agents C14569-A
Isotretinoin
Isturisa (osilodrostat)
Kanuma (sebelipase alfa) C9974-A
Keveyis (dichlorphenamide)
Korlym (mifepristone)
Korsuva (difelikefalin) C23743-A
Kuvan (sapropterin dihydrochloride)
Lemtrada (alemtuzumab) C6919-A
Leqvio (inclisiran)
Leuprolide long acting (Lupron Depot, Eligard, Lupron Depot Ped, Fensolvi, Camcevi)
Lidocaine Patch
Livtencity (maribavir)
Lumizyme (alglucosidase alfa) C8716-A
Lupkynis (voclosporin)
Lyrica_Lyrica CR (pregabalin_pregabalin ER)
Mepron (atovaquone)
Myalept (metreleptin)
Nasal Steroids
NexoBrid (anacaulase-bcdb) C25200-A
Nexviazyme (avalglucosidase alfa-ngpt) C21948-A
Nitisinone (Orfadin, Nityr)
Northera (droxidopa)
Nplate (romiplostim) C6662-A
Nuedexta (dextromethorphan/quinidine)
Nulibry (fosdenopterin) C21306-A
Nuplazid (pimavanserin)
Ocrevus (ocrelizumab) C11250-A
Octreotide
Off-Label Use of Drugs and Biologic Agents
Onpattro (patisiran)_Tegsedi (inotersen)
Oxervate (cenegermin)
Oxlumo (lumasiran) C21126-A
Palynziq (pegvaliase-pqpz)
Parsabiv (etelcalcetide) C17883-A
Penicillamine (Depen, Cuprimine), Trientine (Cuvrior, Syprine)
Prescription Compounded Product
Prevymis (letermovir)
Procysbi, Cystagon (cysteamine bitartrate) C6355-B
Pulmozyme (dornase alfa)
Prolia (denosumab) C8848-A
Pyrukynd (mitapivat)
Pulmonary Arterial Hypertension (PAH) C9837-A
Qutenza (capsaicin) C2809-A
Radicava (edaravone)
Ravicti (glycerol phenylbutyrate)
Recorlev (levoketoconazole)
Regranex (becaplermin)
Relizorb (immobilized lipase cartridge) MNR C17943-A
Relyvrio (sodium phenylbutyrate/taurursodiol)
Revcovi (elapegademase) C16329-A
Riluzole (Rilutek/Tiglutik/Exservan)
Ryplazim (human plasminogen) C22238-A
Santyl (collagenase)
Savella (milnacipran)
Sensipar (cinacalcet)
Signifor (pasireotide diaspartate) C15367-A
Serotonin - Norepinephrine Reuptake Inhibitors (SNRI)
Sexual Dysfunction Criteria NC
Seysara (sarecycline)
Sodium Oxybate (Lumryz, Xyrem, Xywav)
Soliris (eculizumab), Ultomiris (ravulizumab) C4867-A
Spevigo (spesolimab-sbzo) C24676-A
Standard Oncology Criteria
Strensiq (asfotase alfa)
Synarel (nafarelin acetate, nasal solution)
Testosterone
Thiola (tiopronin)
Tysabri (natalizumab) C10276-A
Tolvaptan
Tzield (teplizumab-mzwv) C24729-A
Uplizna (inebilizumab-cdon) C20171-A
Valcyte (valganciclovir)
Vibrant (transient device for constipation) NC
Vijoice (alpelisib)
Viltepso (viltolarsen) MNR C20406-A
Vimizim (elosulfase alfa) C7068-A
Voxzogo (vosoritide)
Vyndaqel (tafamidis meglumine), Vyndamax (tafamidis)
Xenpozyme (olipudase alfa-rpcp) C24670-A
Xermelo (telotristat ethyl)
Zemplar (paricalcitol)
Zokinvy (lonafarnib)
Zoladex (goserelin acetate) C8757-A
Ztalmy (ganaxolone)
- Step Therapy
Plan restrictions for certain Formulary drugs may require that other drugs be tried first . Nebraska Medicaid’s Preferred Drug List (PDL) designates which drugs require step therapy. Drug samples from Providers or manufacturers are not considered as meeting step therapy requirements or as justification for exception requests.
- Pharmacy Billing
MAC Pricing (Maximum Allowable Cost)
CVS Nebraska Implementation Guide
Nebraska Pharmacy Part D Copay Faxblast
For claims older than 30 days, pharmacies may submit paper claims by using a universal claim form.
Forms can be obtained at this link: NCPDP- Universal Claim Forms
CVS Caremark
PO Box 52136
Phoenix, AZ 85072-2136 - Prescription Drug Monitoring Program (PDMP)
- Drug Recalls
For a list of recalled drugs please refer to the FDA Drug Recalls page.